A physiologically based pharmacokinetic model for retinoic acid and its metabolites
- 31 March 1997
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 36 (3), S77-S85
- https://doi.org/10.1016/s0190-9622(97)70063-x
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A developmental toxicity study of tretinoin administered topically and orally to pregnant Wistar ratsJournal of the American Academy of Dermatology, 1997
- The percutaneous absorption of topically applied tretinoin and its effect on endogenous concentrations of tretinoin and its metabolites after single doses or long-term useJournal of the American Academy of Dermatology, 1997
- Physiologically-Based Pharmacokinetic Modeling and Bioactivation of XenobioticsToxicology and Industrial Health, 1994
- Dose-Dependent Pharmacokinetics of All-trans-Retinoic AcidJNCI Journal of the National Cancer Institute, 1992
- A physiologically based kinetic model of rat and mouse gestation: Disposition of a weak acidToxicology and Applied Pharmacology, 1992
- Teratogenicity of all‐trans retinoic acid during early embryonic development in the cynomolgus monkey (Macaca fascicularis)Teratology, 1992
- Biologically Motivated Models for Chemical Risk AssessmentHealth Physics, 1989
- Pharmacokinetics of Isotretinoin Following a Single Oral DoseThe Journal of Clinical Pharmacology, 1982
- Distribution and excretion of 2,2′,4,4′,5,5′-hexabromobiphenyl in rats and man: Pharmacokinetic model predictionsToxicology and Applied Pharmacology, 1980
- Methotrexate PharmacokineticsJournal of Pharmaceutical Sciences, 1971